| 04/13/2016 | Hospira | 50% Magnesium Sulfate Injection, USP | Particulate Matter | Hospira, Inc. |
Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Friday, April 15, 2016
50 Percent Magnesium Sulfate Injection, USP by Hospira: Recall - Presence Of Particulate Matter Administration may result in localized swelling, redness, pain at the site of administration or veins, allergic reactions to the foreign particle, microembolic effects as well as possible fetal harm. Posted 04/14/2016
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment